Chennai: Biotechnology firm Shire India, has announced the availability of DosEdge, a mobile app that is designed to aid healthcare professionals in determining the appropriate dosage of antihemophilic factor/drug.
A release from the firm stated that DosEdge safeguards dosage accuracy and reduces the incidence of error, thereby helping physicians develop personalized dosing regimens tailored to specific needs of their respective patients.
The app is free and is currently available to healthcare professionals through the Apple App Store and Google Play Store. It uses data analysis to make accurate and critical dosage calculations for factor replacement.
“As part of our commitment to meeting the unmet needs of hemophilia patients, we are pleased to introduce DoseEdge, an innovative mobile app for healthcare professionals in India,” said country head, Shire India, Vineet Singhal.